RPT-CureVac to withdraw first-generation COVID-19 vaccine candidate
(Repeats to more subscribers)BERLIN, Oct 12 (Reuters) - CureVac will withdraw its first-generation COVID-19 vaccine candidate and focus on collaborating with GSK to develop second-generation mRNA vaccine technology instead, the Germany-based biote...
Read more